These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Microneedle scleral patch for minimally invasive delivery of triamcinolone to the posterior segment of eye. Roy G; Garg P; Venuganti VVK Int J Pharm; 2022 Jan; 612():121305. PubMed ID: 34800618 [TBL] [Abstract][Full Text] [Related]
8. Episcleral drug film for better-targeted ocular drug delivery and controlled release using multilayered poly-ε-caprolactone (PCL). Sun S; Li J; Li X; Lan B; Zhou S; Meng Y; Cheng L Acta Biomater; 2016 Jun; 37():143-54. PubMed ID: 27071973 [TBL] [Abstract][Full Text] [Related]
9. Sustained release of triamcinolone acetonide from an episcleral plaque of multilayered poly-ε-caprolactone matrix. Meng Y; Sun S; Li J; Nan K; Lan B; Jin Y; Chen H; Cheng L Acta Biomater; 2014 Jan; 10(1):126-33. PubMed ID: 24076072 [TBL] [Abstract][Full Text] [Related]
10. Topical instillation of triamcinolone acetonide-loaded emulsomes for posterior ocular delivery: statistical optimization and in vitro-in vivo studies. Kapadia R; Parikh K; Jain M; Sawant K Drug Deliv Transl Res; 2021 Jun; 11(3):984-999. PubMed ID: 32567039 [TBL] [Abstract][Full Text] [Related]
11. The effect of ocular pigmentation on transscleral delivery of triamcinolone acetonide. Du W; Sun S; Xu Y; Li J; Zhao C; Lan B; Chen H; Cheng L J Ocul Pharmacol Ther; 2013 Sep; 29(7):633-8. PubMed ID: 23597073 [TBL] [Abstract][Full Text] [Related]
12. Ocular Disposition of ∆ Punyamurthula NS; Adelli GR; Gul W; Repka MA; ElSohly MA; Majumdar S AAPS PharmSciTech; 2017 Aug; 18(6):1936-1945. PubMed ID: 27905004 [TBL] [Abstract][Full Text] [Related]
13. Safety and pharmacodynamics of suprachoroidal injection of triamcinolone acetonide as a controlled ocular drug release model. Chen M; Li X; Liu J; Han Y; Cheng L J Control Release; 2015 Apr; 203():109-17. PubMed ID: 25700623 [TBL] [Abstract][Full Text] [Related]
14. Directing the nanoparticle formation by the combination with small molecular assembly and polymeric assembly for topical suppression of ocular inflammation. Huang J; Yu X; Zhou Y; Zhang R; Song Q; Wang Q; Li X Int J Pharm; 2018 Nov; 551(1-2):223-231. PubMed ID: 30213683 [TBL] [Abstract][Full Text] [Related]
15. The physiochemical, mechanical, and adhesive properties of solvent-cast vitamin E/Soluplus® films. Salawi A; Nazzal S Int J Pharm; 2018 Dec; 552(1-2):378-387. PubMed ID: 30308273 [TBL] [Abstract][Full Text] [Related]
16. Release profile and transscleral permeation of triamcinolone acetonide loaded nanostructured lipid carriers (TA-NLC): in vitro and ex vivo studies. Araújo J; Garcia ML; Mallandrich M; Souto EB; Calpena AC Nanomedicine; 2012 Aug; 8(6):1034-41. PubMed ID: 22115598 [TBL] [Abstract][Full Text] [Related]
17. Ciprofloxacin self-dissolvable Soluplus based polymeric films: a novel proposal to improve the management of eye infections. Guillot AJ; Petalas D; Skondra P; Rico H; Garrigues TM; Melero A Drug Deliv Transl Res; 2021 Apr; 11(2):608-625. PubMed ID: 33528829 [TBL] [Abstract][Full Text] [Related]
18. Sustained release of curcumin self-emulsifying drug delivery system (SEDDS) from solvent-cast Soluplus Kamal MM; Akter S; Al Hagbani T; Salawi A; Nazzal S Pharm Dev Technol; 2021 Dec; 26(10):1102-1109. PubMed ID: 34645368 [TBL] [Abstract][Full Text] [Related]
19. Sustained release from hot-melt extruded matrices based on ethylene vinyl acetate and polyethylene oxide. Almeida A; Brabant L; Siepmann F; De Beer T; Bouquet W; Van Hoorebeke L; Siepmann J; Remon JP; Vervaet C Eur J Pharm Biopharm; 2012 Nov; 82(3):526-33. PubMed ID: 22986082 [TBL] [Abstract][Full Text] [Related]